S D Goodwin|C V Fletcher - JoVE Visualize

Showing results (41-50 of 77) with videos related to

Pageof 8

Sort By:

The Annals of Pharmacotherapy|February 1, 1994

Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazoleT H Grasela, S D Goodwin, M T Pasko, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995

Pretreatment regimens for adverse events related to infusion of amphotericin BS D Goodwin, J D Cleary, C A Walawander, et al.

Pharmacotherapy|August 12, 2000

Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infectionP L Anderson, S E Noormohamed, K Henry, et al.

AIDS (London, England)|November 23, 2000

Indinavir plasma protein binding in HIV-1-infected adultsP L Anderson, R C Brundage, L Bushman, et al.

Antimicrobial Agents and Chemotherapy|July 1, 1997

Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDSC V Fletcher, B K Goodroad, L M Cummins, et al.

JAMA|May 27, 1988

Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complexK Henry, B J Chinnock, R P Quinn, et al.

Antimicrobial Agents and Chemotherapy|May 11, 1991

Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipientsC V Fletcher, J A Englund, C K Edelman, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1988

Ganciclovir pharmacokinetics during renal impairmentK D Lake, C V Fletcher, K R Love, et al.

The American Journal of Medicine|November 30, 1989

Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infectionsH A Gallis, R O Brennan, S D Goodwin, et al.

Clinical Pharmacology and Therapeutics|July 5, 2007

Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trialC V Fletcher, R C Brundage, T Fenton, et al.

Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:

Pageof 8

The Annals of Pharmacotherapy|February 1, 1994

Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazoleT H Grasela, S D Goodwin, M T Pasko, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995

Pretreatment regimens for adverse events related to infusion of amphotericin BS D Goodwin, J D Cleary, C A Walawander, et al.

Pharmacotherapy|August 12, 2000

Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infectionP L Anderson, S E Noormohamed, K Henry, et al.

AIDS (London, England)|November 23, 2000

Indinavir plasma protein binding in HIV-1-infected adultsP L Anderson, R C Brundage, L Bushman, et al.

Antimicrobial Agents and Chemotherapy|July 1, 1997

Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDSC V Fletcher, B K Goodroad, L M Cummins, et al.

JAMA|May 27, 1988

Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complexK Henry, B J Chinnock, R P Quinn, et al.

Antimicrobial Agents and Chemotherapy|May 11, 1991

Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipientsC V Fletcher, J A Englund, C K Edelman, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1988

Ganciclovir pharmacokinetics during renal impairmentK D Lake, C V Fletcher, K R Love, et al.

The American Journal of Medicine|November 30, 1989

Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infectionsH A Gallis, R O Brennan, S D Goodwin, et al.

Clinical Pharmacology and Therapeutics|July 5, 2007

Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trialC V Fletcher, R C Brundage, T Fenton, et al.

Pageof 8